Lunai Bioworks Inc. - Common Stock (LNAI)
1.0122
-0.0478 (-4.51%)
NASDAQ · Last Trade: Dec 17th, 1:42 PM EST
The cell therapy, Dendritic Cell Combination Therapy (DCCT), achieved complete regression of both primary and metastatic pancreatic tumors with no recurrence in humanized preclinical models.
Via Stocktwits · November 25, 2025
Via Benzinga · November 19, 2025
Via Benzinga · November 19, 2025
Via Benzinga · November 5, 2025